Clinical Trial Update: Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing metformin alone versus metformin with a GLP-1 receptor agonist in overweight/obese women with polycystic ovary syndrome (PCOS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• GLP-1 receptor agonist
• metformin (metformin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: UNKNOWN